Back to search
FDAFDA · Food and drugs·Recall number D-1308-2019

Bevacizumab 2.5 mg/0.1 mL, packaged in a Prefilled Syringe, Rx only, AVELLA SPECIALTY PHARMACY 24416 N. 19TH AVENUE PHOENIX, AZ 85085, NDC 42852-001-27

Published June 5, 2019 · Recall initiated: May 3, 2019

Summary

FDA records drug Class II recall D-1308-2019, published June 5, 2019 and initiated May 3, 2019. Recalling firm: Avella of Deer Valley, Inc. Store 38; Status: Terminated; Reported quantity: 730 syringes; Lot: Lot #: 138-20191202@64, Exp 05/13/19. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of assurance of sterility

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Avella of Deer Valley, Inc. Store 38
Distributor
U.S.A. nationwide
Lot
Lot #: 138-20191202@64, Exp 05/13/19
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Bevacizumab 2.5 mg/0.1 mL, packaged in a Prefilled Syringe, Rx only, AVELLA SPECIALTY PHARMACY 24416 N. 19TH AVENUE PHOENIX, AZ 85085, NDC 42852-001-27 recalled?

Yes. FDA published recall D-1308-2019 on June 5, 2019. Reported hazard: Lack of assurance of sterility

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit